Arcus Biosciences, Inc. (RCUS) Margin Analysis - Discounting Cash Flows
RCUS
Arcus Biosciences, Inc.
RCUS (NYSE)

Years and Quarters

Years

Years

The number of historical years used to render the annual chart and tables.

Quarters

Quarters

The number of historical quarters used to render the quarterly chart and tables.

Margin Analysis Report

Margins refer to the ratio between a financial report item and the revenue (example: Net Income Margin = Net Income / Revenue).

This analysis provides annual and quarterly sections for reporting key financial margins.

Annual Section

The annual section uses annual data to calculate margins and growth rates.

Monetary values in USD

amounts except #

LTM
Mar 10
2025
Dec 31
2024
Dec 31
2023
Dec 31
2022
Dec 31
Revenue 247 247 258 117 112
Revenue Growth Rate 0% -4.26% 120.5% 4.46% -70.76%
Cost of Revenue 5 10 0 0 0
Gross Profit 242 237 258 117 112
Gross Margin 97.98% 95.95% 100% 100% 100%
Operating Income -386 -386 -330 -340 -280
Operating Margin -156.3% -156.3% -127.9% -290.6% -250%
Net Income -353 -353 -283 -307 -267
Net Margin -142.9% -142.9% -109.7% -262.4% -238.4%

Monetary values in USD

amounts except #

LTM
Mar 10
2025
Dec 31
2024
Dec 31
2023
Dec 31
2022
Dec 31
Revenue 247 247 258 117 112
Cash from Operating Activities -482 -482 -170 -306 438
Cash from Operating Activities Margin -195.1% -195.1% -65.89% -261.5% 391.1%
Free Cash Flow -484 -484 -176 -330 432
Free Cash Flow Margin -196% -196% -68.22% -282.1% 385.7%
Depreciation and Amortization 10 10 10 8 14
Depreciation and Amortization Margin 4.05% 4.05% 3.88% 6.84% 12.5%
Capital Expenditure -2 -2 -6 -24 -6
Capital Expenditure Margin -0.81% -0.81% -2.33% -20.51% -5.36%

Annual Chart

Monetary values in USD

Quarterly Section

The quarterly section uses quarterly data to calculate margins and growth rates.

Monetary values in USD

amounts except #

2025 (Q4)
Dec 31
2025 (Q3)
Sep 30
2025 (Q2)
Jun 30
2025 (Q1)
Mar 31
2024 (Q4)
Dec 31
2024 (Q3)
Sep 30
2024 (Q2)
Jun 30
2024 (Q1)
Mar 31
2023 (Q4)
Dec 31
Revenue 33 26 160 28 26 48
Revenue Growth Rate 26.92% -83.75% 471.4% 7.69% -45.83%
Cost of Revenue 3 2 0 0 0 0
Gross Profit 30 24 160 28 26 48
Gross Margin 90.91% 92.31% 100% 100% 100% 100%
Operating Income -114 -142 -8 -122 -103 -105
Operating Margin -345.5% -546.2% -5% -435.7% -396.2% -218.8%
Net Income -98 -135 -8 -112 -94 -92
Net Margin -297% -519.2% -5% -400% -361.5% -191.7%

Monetary values in USD

amounts except #

2025 (Q4)
Dec 31
2025 (Q3)
Sep 30
2025 (Q2)
Jun 30
2025 (Q1)
Mar 31
2024 (Q4)
Dec 31
2024 (Q3)
Sep 30
2024 (Q2)
Jun 30
2024 (Q1)
Mar 31
2023 (Q4)
Dec 31
Revenue 33 26 160 28 26 48
Cash from Operating Activities -120 -97 -133 -132 -100 26
Cash from Operating Activities Margin -363.6% -373.1% -83.12% -471.4% -384.6% 54.17%
Free Cash Flow -121 -97 -133 -133 -101 25
Free Cash Flow Margin -366.7% -373.1% -83.12% -475% -388.5% 52.08%
Depreciation and Amortization 3 2 2 3 3 2
Depreciation and Amortization Margin 9.09% 7.69% 1.25% 10.71% 11.54% 4.17%
Capital Expenditure -1 0 0 -1 -1 -1
Capital Expenditure Margin -3.03% 0% 0% -3.57% -3.85% -2.08%

Quarterly Chart

Monetary values in USD

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program